FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer

Published:2007-06-01 Issue:6 Volume:12 Page:713-718
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Cohen Martin H.¹,Gootenberg Joe¹,Keegan Patricia¹,Pazdur Richard¹

Affiliation:

1. Division of Biological Oncology Products, Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA

Abstract

Learning Objectives After completing this course, the reader will be able to: Describe the bevacizumab mechanism of action.List the current bevacizumab indications.Discuss the role of bevacizumab in the treatment of specific non-small cell lung cancer histologies.Describe the clinical trial design leading to bevacizumab approval by the FDA.Identify the major adverse events associated with bevacizumab treatment. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-6-713

Reference10 articles.

1. Lessons from phase III clinical trials on anti-VEGF therapy for cancer;Jain;Nat Clin Pract Oncol,2006

2. Clinical translation of angiogenesis inhibitors;Kerbel;Nat Rev Cancer,2002

3. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer;Ferrara;Nat Rev Drug Discov,2004

4. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

5. An update on North American randomized studies in non-small cell lung cancer;Bunn;Semin Oncol,1998

Cited by 343 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving glioma drug delivery: A multifaceted approach for glioma drug development;Pharmacological Research;2024-10

2. Intraocular and extraocular manifestations of thyroid dysfunction in Danish patients – A Nationwide Study;Acta Ophthalmologica;2024-09

3. A weighted combination of reproducing kernel particle shape functions with cardinal functions of scalable polyharmonic spline radial kernel utilized in Galerkin weak form of a mathematical model related to anti-angiogenic therapy;Communications in Nonlinear Science and Numerical Simulation;2024-08

4. Innovating Cancer Treatment Through Cell Cycle, Telomerase, Angiogenesis, and Metastasis;DNA and Cell Biology;2024-07-17

5. Photoimmunotherapy of HER2-expressing Breast Cancer Cells;Cancer Genomics - Proteomics;2024-06-29